Adipocytes as immune cells: Differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development

Journal of Immunology

Volumn 183, Issue 9, 2009, Pages 5948-5956

  Alexaki, Vassilia Ismini ^a   Notas, George ^a   Pelekanou, Vassiliki ^a,c   Kampa, Marilena ^a   Valkanou, Maria ^a   Theodoropoulos, Panayiotis ^a   Stathopoulos, Efstathios N ^a   Tsapis, Andreas ^b   Castanas, Elias ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b SAINT LOUIS HOSPITAL   (France)

^c JULES BORDET INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; B CELL ACTIVATING FACTOR RECEPTOR; B CELL MATURATION ANTIGEN; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; TUMOR NECROSIS FACTOR;

ADIPOGENESIS; ADIPOSE TISSUE; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; MESENCHYME CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPOCYTES; ADIPOSE TISSUE; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-CELL MATURATION ANTIGEN; CELL DIFFERENTIATION; CELLS, CULTURED; HUMANS; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13; TUMOR NECROSIS FACTORS;

EID: 77950677297     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0901186     Document Type: Article

References (52)

1. Tsatsanis, C., V. Zacharioudaki, A. Androulidaki, E. Dermitzaki, I. Charalampopoulos, V. Minas, A. Gravanis, and A. N. Margioris. 2006. Peripheral factors in the metabolic syndrome: the pivotal role of adiponectin. Ann. NY Acad. Sci. 1083: 185-195.
2. Schaffler, A., J. Scholmerich, and B. Salzberger. 2007. Adipose tissue as an immunological organ: Toll-like receptors, C1q/TNFs and CTRPs. Trends Immunol. 28: 393-399.
3. Bodmer, J. L., P. Schneider, and J. Tschopp. 2002. The molecular architecture of the TNF superfamily. Trends Biochem. Sci. 27: 19-26.
4. Hahne, M., T. Kataoka, M. Schroter, K. Hofmann, M. Irmler, J. L. Bodmer, P. Schneider, T. Bornand, N. Holler, L. E. French, et al. 1998. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med. 188: 1185-1190.
5. Kelly, K., E. Manos, G. Jensen, L. Nadauld, and D. A. Jones. 2000. APRIL/TRDL-1, a tumor necrosis factor-like ligand, stimulates cell death. Cancer Res. 60: 1021-1027. (Pubitemid 30129540)
6. Shu, H. B., W. H. Hu, and H. Johnson. 1999. TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukocyte Biol. 65: 680-683. (Pubitemid 29227061)
7. Gross, J. A., J. Johnston, S. Mudri, R. Enselman, S. R. Dillon, K. Madden, W. Xu, J. Parrish-Novak, D. Foster, C. Lofton-Day, et al. 2000. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404: 995-999.
8. Schneider, P., F. MacKay, V. Steiner, K. Hofmann, J. L. Bodmer, N. Holler, C. Ambrose, P. Lawton, S. Bixler, H. Acha-Orbea, et al. 1999. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med. 189: 1747-1756.
9. Moore, P. A., O. Belvedere, A. Orr, K. Pieri, D. W. LaFleur, P. Feng, D. Soppet, M. Charters, R. Gentz, D. Parmelee, et al. 1999. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285: 260-263.
10. Ng, L. G., C. R. Mackay, and F. Mackay. 2005. The BAFF/APRIL system: life beyond B lymphocytes. Mol. Immunol. 42: 763-772.
11. Guan, Z. B., W. B. Dan, Y. Shui, J. L. Ye, and S. Q. Zhang. 2007. cDNA cloning, expression and bioactivity of porcine BAFF. Dev. Comp. Immunol. 31: 1211-1219.
12. Gras, M. P., Y. Laabi, G. Linares-Cruz, M. O. Blondel, J. P. Rigaut, J. C. Brouet, G. Leca, R. Haguenauer-Tsapis, and A. Tsapis. 1995. BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. Int. Immunol. 7: 1093-1106.
13. Dillon, S. R., J. A. Gross, S. M. Ansell, and A. J. Novak. 2006. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat. Rev. Drug Discov. 5: 235-246.
14. Hendriks, J., L. Planelles, J. de Jong-Odding, G. Hardenberg, S. T. Pals, M. Hahne, M. Spaargaren, and J. P. Medema. 2005. Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation. Cell Death Differ. 12: 637-648.
15. Ingold, K., A. Zumsteg, A. Tardivel, B. Huard, Q. G. Steiner, T. G. Cachero, F. Qiang, L. Gorelik, S. L. Kalled, H. Acha-Orbea, et al. 2005. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201: 1375-1383.
16. Sakurai, D., H. Hase, Y. Kanno, H. Kojima, K. Okumura, and T. Kobata. 2007. TACI regulates IgA production by APRIL in collaboration with HSPG. Blood 109: 2961-2967.
17. Kimberley, F. C., L. van Bostelen, K. Cameron, G. Hardenberg, J. A. Marquart, M. Hahne, and J. P. Medema. 2009. The proteoglycan (heparan sulfate proteoglycan) binding domain of APRIL serves as a platform for ligand multimerization and cross-linking. FASEB J. 23: 1584-1595.
18. Thompson, J. S., S. A. Bixler, F. Qian, K. Vora, M. L. Scott, T. G. Cachero, C. Hession, P. Schneider, I. D. Sizing, C. Mullen, et al. 2001. BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF. Science 293: 2108-2111.
19. Hatzoglou, A., J. Roussel, M. F. Bourgeade, E. Rogier, C. Madry, J. Inoue, O. Devergne, and A. Tsapis. 2000. TNF receptor family member BCMA (B cell maturation) associates with TNF receptor-associated factor (TRAF) 1, TRAF2, and TRAF3 and activates NF-κB, elk-1, c-Jun N-terminal kinase, and p38 mitogen-activated protein kinase. J. Immunol. 165: 1322-1330.
20. Mackay, F., and C. Ambrose. 2003. The TNF family members BAFF and APRIL: the growing complexity. Cytokine Growth Factor Rev. 14: 311-324.
21. Burkly, L. C., J. S. Michaelson, K. Hahm, A. Jakubowski, and T. S. Zheng. 2007. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/ Fn14 pathway in health and disease. Cytokine 40: 1-16.
22. Chicheportiche, Y., P. R. Bourdon, H. Xu, Y. M. Hsu, H. Scott, C. Hession, I. Garcia, and J. L. Browning. 1997. TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis. J. Biol. Chem. 272: 32401-32410.
23. Girgenrath, M., S. Weng, C. A. Kostek, B. Browning, M. Wang, S. A. Brown, J. A. Winkles, J. S. Michaelson, N. Allaire, P. Schneider, et al. 2006. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J. 25: 5826-5839.
24. Jakubowski, A., C. Ambrose, M. Parr, J. M. Lincecum, M. Z. Wang, T. S. Zheng, B. Browning, J. S. Michaelson, M. Baetscher, B. Wang, D. M. Bissell, and L. C. Burkly. 2005. TWEAK induces liver progenitor cell proliferation. J. Clin. Invest. 115: 2330-2340.
25. Duffield, J. 2003. The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. (Lond.) 104: 27-38.
26. Pelekanou, V., M. Kampa, M. Kafousi, K. Darivianaki, E. Sanidas, D. D. Tsiftsis, E. N. Stathopoulos, A. Tsapis, and E. Castanas. 2008. Expression of TNF-super-family members BAFF and APRIL in breast cancer: immunohistochemical study in 52 invasive ductal breast carcinomas. BMC Cancer 8: 76.
27. Bunnell, B. A., M. Flaat, C. Gagliardi, B. Patel, and C. Ripoll. 2008. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 45: 115-120.
28. Hauner, H., G. Entenmann, M. Wabitsch, D. Gaillard, G. Ailhaud, R. Negrel, and E. F. Pfeiffer. 1989. Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. J. Clin. Invest. 84: 1663-1670.
29. Cawthorn, W. P., and J. K. Sethi. 2008. TNF-α and adipocyte biology. FEBS Lett. 582: 117-131.
30. Furlong, M. A., J. C. Fanburg-Smith, and M. Miettinen. 2001. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am. J. Surg. Pathol. 25: 809-814.
31. Burjanadze, M., E. Roosnek, J. Passweg, and B. Huard. 2009. [APRIL, the spring of plasmocytes.] Med. Sci. (Paris) 25: 5-8.
32. Rafei, M., J. Hsieh, S. Fortier, M. Li, S. Yuan, E. Birman, K. Forner, M. N. Boivin, K. Doody, M. Tremblay, B. Annabi, and J. Galipeau. 2008. Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction. Blood 112: 4991-4998.
33. Daher, S. R., B. H. Johnstone, D. G. Phinney, and K. L. March. 2008. Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells 26: 2664-2665.
34. Jeong, J. 2008. Adipose stem cells as a clinically available and effective source of adult stem cell therapy. Int. J. Stem Cells 1: 43-48.
35. Tonnesen, M. G. 1989. Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium. J. Invest. Dermatol. 93: 53S-58S.
36. Young, H. E., M. L. Mancini, R. P. Wright, J. C. Smith, A. C. Black, Jr., C. R. Reagan, and P. A. Lucas. 1995. Mesenchymal stem cells reside within the connective tissues of many organs. Dev. Dyn. 202: 137-144.
37. Case, J., T. L. Horvath, J. C. Howell, M. C. Yoder, K. L. March, and E. F. Srour. 2005. Clonal multilineage differentiation of murine common pluripotent stem cells isolated from skeletal muscle and adipose stromal cells. Ann. NY Acad. Sci. 1044: 183-200.
38. Case, J., T. L. Horvath, C. B. Ballas, K. L. March, and E. F. Srour. 2008. In vitro clonal analysis of murine pluripotent stem cells isolated from skeletal muscle and adipose stromal cells. Exp. Hematol. 36: 224-234.
39. Mishra, P. J., P. J. Mishra, J. W. Glod, and D. Banerjee. 2009. Mesenchymal stem cells: flip side of the coin. Cancer Res. 69: 1255-1258.
40. Mishra, P. J., P. J. Mishra, R. Humeniuk, D. J. Medina, G. Alexe, J. P. Mesirov, S. Ganesan, J. W. Glod, and D. Banerjee. 2008. Carcinoma-associated fibroblastlike differentiation of human mesenchymal stem cells. Cancer Res. 68: 4331-4339.
41. Hotamisligil, G. S., N. S. Shargill, and B. M. Spiegelman. 1993. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259: 87-91.
42. Kishore, U., M. S. Kojouharova, and K. B. Reid. 2002. Recent progress in the understanding of the structure-function relationships of the globular head regions of C1q. Immunobiology 205: 355-364. (Pubitemid 35153953)
43. Kishore, U., and K. B. Reid. 2000. C1q: structure, function, and receptors. Immunopharmacology 49: 159-170.
44. Mackay, F., P. A. Silveira, and R. Brink. 2007. B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr. Opin. Immunol. 19: 327-336.
45. Pelekanou, V., M. Kampa, and E. Castanas. 2007. Potentiation of erythropoietin (EPO) action by membrane steroid receptor agonists. Breast Cancer 16 (Suppl. 1): s14-s15.
46. Moreaux, J., J. L. Veyrune, J. De Vos, and B. Klein. 2009. APRIL is overexpressed in cancer: link with tumor progression. BMC Cancer 9: 83.
47. Roosnek, E., M. Burjanadze, P. Y. Dietrich, T. Matthes, J. Passweg, and B. Huard. 2009. Tumors that look for their springtime in APRIL. Crit. Rev. Oncol. Hematol. In press.
48. Deshayes, F., G. Lapree, A. Portier, Y. Richard, P. Pencalet, D. Mahieu-Caputo, P. Horellou, and A. Tsapis. 2004. Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor. Oncogene 23: 3005-3012.
49. Chiu, A., W. Xu, B. He, S. R. Dillon, J. A. Gross, E. Sievers, X. Qiao, P. Santini, E. Hyjek, J. W. Lee, et al. 2007. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL. Blood 109: 729-739.
50. Tang, W., D. Zeve, J. M. Suh, D. Bosnakovski, M. Kyba, R. E. Hammer, M. D. Tallquist, and J. M. Graff. 2008. White fat progenitor cells reside in the adipose vasculature. Science 322: 583-586.
51. Blanco-Colio, L. M., J. L. Martin-Ventura, B. Munoz-Garcia, J. A. Moreno, O. Meilhac, A. Ortiz, and J. Egido. 2007. TWEAK and Fn14: new players in the pathogenesis of atherosclerosis. Front Biosci. 12: 3648-3655.
52. Schaffler, A., U. Muller-Ladner, J. Scholmerich, and C. Buchler. 2006. Role of adipose tissue as an inflammatory organ in human diseases. Endocr. Rev. 27: 449-467.